Morgan Stanley’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
|
|||||
|
2020
Q1 | $15.3M | Sell |
|
|||||
|
2019
Q4 | $15.2M | Buy |
|
|||||
|
2019
Q3 | $393K | Buy |
|
|||||
|
2019
Q2 | $206K | Sell |
|
|||||
|
2019
Q1 | $2.33M | Buy |
|
|||||
|
2018
Q4 | $406K | Sell |
|
|||||
|
2018
Q3 | $470K | Sell |
|
|||||
|
2018
Q2 | $316K | Sell |
|
|||||
|
2018
Q1 | $191K | Buy |
|
|||||
|
2017
Q4 | $207K | Buy |
|
|||||
|
2017
Q3 | $220K | Buy |
|
|||||
|
2017
Q2 | $205K | Buy |
|
|||||
|
2017
Q1 | $231K | Sell |
|
|||||
|
2016
Q4 | $363K | Buy |
|